COVID-19 Impact on Breast Cancer Treatment, Accommodations in Oncology and Support
Dear LBCA Subscribers,
This has been a difficult time for all breast cancer patients, including those of us living with lobular breast cancer. Whether newly diagnosed or undergoing active treatment, COVID-19 has complicated our lives as patients. Many of us have experienced treatment modifications and in many cases, diagnosis and treatment delays. Doctors must balance new safety issues with the risk of changing or delaying testing, imaging, surgeries, and other treatments in each individual case. In some cases, financial barriers have also made it more difficult for many to obtain medical care, maintain good nutrition, retain health insurance coverage, and afford transportation to appointments.
Please be assured that through it all, LBCA continues to provide the most up to date news, information and research about lobular breast cancer
. As always, remember to discuss your treatment options with your health care team.
LBCA maintains strong partnerships with breast cancer organizations that can support patients with lobular breast cancer in these challenging times. SHARE Cancer Support
(844-ASK-SHARE ) and After Breast Cancer Diagnosis
(800-977-4121) provide support over the telephone and in some cases, groups via videoconference. Find answers to many questions about cancer patients and COVID-19 at the American Society of Clinical Oncology’s doctor-approved patient information website Cancer.Net
. Stay Safe!
Laurie Hutcheson, Executive Director